Friday, July 10, 2026

Drug profile · INN

cefazolin

cefazolin (CEPHAZOLIN VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — cefazolin

Quick answer

cefazolin (CEPHAZOLIN VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN cefazolin
Brand CEPHAZOLIN VIATRIS

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. APHP180605 Phase 3 · PARItec · Excision-autograft surgery in burn patient
  2. APHP220763 Phase 3 · PARItec · Catheter related bloodstream infections due to Staphylococcu
  3. MGT-RPGR-022 Phase 3 · Janssen-Cilag International N.V · X-Linked Retinitis Pigmentosa caused by mutations in the RPG
  4. APHP 180672 Phase 2 · PARItec · acute osteomyelitis of the child
  5. CEFAZOLIN Approved · PARItec · Infection prophylaxis
  6. Cefazolin with Daptomycin Unknown · Hospital Authority · Periprosthetic Joint Infection

Frequently asked questions

What is cefazolin?

cefazolin (CEPHAZOLIN VIATRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for cefazolin?

CEPHAZOLIN VIATRIS is a marketed brand name for cefazolin. Check FDA Drugs@FDA for the current US label holder and prescribing information.